The measure provides for the inoculation with Cuban drugs, and in a “gradual manner,” of medical students, health and pharmaceutical industry workers, as well as population groups from selected territories at risk of contagion with COVID-19.
by OnCuba Staff
This Wednesday the intervention began in the Havana municipalities of Regla, Guanabacoa, Habana del Este and San Miguel del Padrón, where nearly 400,000 people over 19 will receive the COVID-19 shot. The applied strategy prioritizes at first those over 60 years of age, to later be extended to the rest of the age groups.
According to the source, in the coming weeks the municipalities of Arroyo Naranjo, Boyeros and Cotorro, in which it is expected that close to 383,000 residents will be vaccinated, will join the vaccination campaign with the Abdala candidate, developed by the Center for Genetic Engineering and Biotechnology (CIGB).
For its part, in a second stage of the health intervention in the Cuban capital, scheduled to begin in the second half of June, the first doses of the Sovereign 02 candidate—developed by the Finlay Vaccine Institute—will be applied to the volunteers of the municipalities of Plaza, Playa, Centro Habana, Old Havana, Cerro, Diez de Octubre, La Lisa and Marianao.
The Cuban health authorities hope that 1.7 million inhabitants of the capital city will be inoculated with one of the two Cuban vaccine candidates, currently in Phase III of clinical trials and awaiting data on its efficacy against the virus. Meanwhile, in Santiago de Cuba, Matanzas, Pinar del Río and the special municipality of Isla de la Juventud, health personnel and clinical sites are already preparing for vaccination.
Comments are closed.